Establishment of Hepatitis C Virus RNA-Replicating Cell Lines Possessing Ribavirin-Resistant Phenotype

BACKGROUND: Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved therapy using direct acting antivirals for patients with chronic hepatitis C. However, the precise mechanisms underlying RBV action against hepatitis C virus (HCV) replication are not yet understood....

Descripción completa

Detalles Bibliográficos
Autores principales: Satoh, Shinya, Mori, Kyoko, Ueda, Youki, Sejima, Hiroe, Dansako, Hiromichi, Ikeda, Masanori, Kato, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336140/
https://www.ncbi.nlm.nih.gov/pubmed/25699517
http://dx.doi.org/10.1371/journal.pone.0118313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336140/
https://www.ncbi.nlm.nih.gov/pubmed/25699517
http://dx.doi.org/10.1371/journal.pone.0118313

Ejemplares similares